TYG Index as a Novel Predictor of Clinical Outcomes in Advanced Chronic Heart Failure with Renal Dysfunction Patients
Chang Su,Zeyu Wang,Zhen Qin,Yan Lv,Yachen Hou,Ge Zhang,Mengdie Cheng,Xinyue Cui,Zhiyu Liu,Pengchong Du,Tianding Liu,Peiyu Yuan,Junnan Tang,Jinying Zhang
DOI: https://doi.org/10.2147/cia.s462542
IF: 3.829
2024-04-30
Clinical Interventions in Aging
Abstract:Chang Su, 1– 3 Zeyu Wang, 4 Zhen Qin, 1– 3 Yan Lv, 1– 3 Yachen Hou, 1– 3 Ge Zhang, 1– 3 Mengdie Cheng, 1– 3 Xinyue Cui, 1– 3 Zhiyu Liu, 1– 3 Pengchong Du, 1– 3 Tianding Liu, 1– 3 Peiyu Yuan, 1– 3 Junnan Tang, 1– 3 Jinying Zhang 1– 3 1 Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China; 2 Key Laboratory of Cardiac Injury and Repair of Henan Province, Zhengzhou, Henan, People's Republic of China; 3 Henan Province Clinical Research Center for Cardiovascular Diseases, Zhengzhou, Henan, People's Republic of China; 4 Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China Correspondence: Junnan Tang; Jinying Zhang, Department of Cardiology, First Affiliated Hospital of Zhengzhou University, No. 1 Eastern Jianshe Road, Zhengzhou, Henan, 450052, People's Republic of China, Tel +86 15890696166 ; +86 13503830283, Email ; Background: The triglyceride-glucose (TYG) index is a novel and reliable marker reflecting insulin resistance. Its predictive ability for cardiovascular disease onset and prognosis has been confirmed. However, for advanced chronic heart failure (acHF) patients, the prognostic value of TYG is challenged due to the often accompanying renal dysfunction (RD). Therefore, this study focuses on patients with aHF accompanied by RD to investigate the predictive value of the TYG index for their prognosis. Methods and Results: 717 acHF with RD patients were included. The acHF diagnosis was based on the 2021 ESC criteria for acHF. RD was defined as the eGFR < 90 mL/(min/1.73 m 2 ). Patients were divided into two groups based on their TYG index values. The primary endpoint was major adverse cardiovascular events (MACEs), and the secondary endpoints is all-cause mortality (ACM). The follow-up duration was 21.58 (17.98– 25.39) months. The optimal cutoff values for predicting MACEs and ACM were determined using ROC curves. Hazard factors for MACEs and ACM were revealed through univariate and multivariate COX regression analyses. According to the univariate COX regression analysis, high TyG index was identified as a risk factor for MACEs (hazard ratio = 5.198; 95% confidence interval [CI], 3.702– 7.298; P < 0.001) and ACM (hazard ratio = 4.461; 95% CI, 2.962– 6.718; P < 0.001). The multivariate COX regression analysis showed that patients in the high TyG group experienced 440.2% MACEs risk increase (95% CI, 3.771– 7.739; P < 0.001) and 406.2% ACM risk increase (95% CI, 3.268– 7.839; P < 0.001). Kaplan-Meier survival analysis revealed that patients with high TyG index levels had an elevated risk of experiencing MACEs and ACM within 30 months. Conclusion: This study found that patients with high TYG index had an increased risk of MACEs and ACM, and the TYG index can serve as an independent predictor for prognosis. Keywords: TyG index, advanced chronic heart failure, renal dysfunction, prognosis factor Heart failure (HF) is the final stage of various heart diseases. In recent years, with improvements in the treatment of related diseases such as acute myocardial infarction, the mortality rate of patients has significantly decreased, while the incidence of HF has been steadily rising. 1 Due to the reduced circulatory capacity caused by advanced chronic heart failure (acHF), it often leads to secondary organ complications, with renal dysfunction (RD) being one of the most common complications of acHF. The conflicting treatment principles between these two organs, coupled with the propensity of both to cause systemic complications, often result in frequent readmissions for patients with both CHF and RF, greatly impacting their quality of life. 2,3 Metabolic syndrome can be regarded as the root cause of cardiovascular diseases. In the case of the most common cardiovascular disease, coronary heart disease, prolonged abnormalities in glucose and lipid metabolism lead to endothelial dysfunction and lipid accumulation, triggering the formation of atherosclerosis. 4 Compared to other patients with coronary heart disease, those with glucose and lipid metabolism abnormalities often exhibit more severe coronary artery lesions and a worse clinical prognosis. 5 Patients with glucose and lipid metabolism abnormalities are also more prone to postoperative complications such as cerebral infarction and in-stent restenosis. 6,7 For patients with chronic RD, although there is currently no term like "metabolic syndrome renal disease", the association between the two -Abstract Truncated-
geriatrics & gerontology,gerontology